Pei-Lin  Lee

Dr. Pei-Lin Lee


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KKKun-Tai Kang
Kun-Tai Kang
CCChen-Han Chou
Chen-Han Chou
WEN-CHIN WENGWEN-CHIN WENG
WEN-CHIN WENG
PLPei-Lin Lee
Pei-Lin Lee
WHWei-Chung Hsu
Wei-Chung Hsu
To investigate the contributions of adenoid and tonsil size to childhood obstructive sleep apnea (OSA) and the interactions between adenotonsillar hypertrophy, age, and obesity in children with OSA. In total, 495 symptomatic patients were recruited. The patients were assigned to four groups according to age:toddler (age 1-3, n=42), preschool (age 3-6, n=164), school (age 6-12, n=200), and adolescence (age 12-18, n=89). All subjects had tonsil size graded by otolaryngologists, adenoid size determined on lateral radiographs (Fujioka method), and a full-night polysomnography. The apnea-hypopnea index (AHI), adenoid size, and tonsil size were compared in obese and non-obese children in the four age groups. Adjusted odds ratios (ORs) and 95% confidence interval (CI) of adenotonsillar hypertrophy and OSA risk were estimated by multi-logistic regression. The AHI was positively related to tonsil grade (r=0.33, p <0.001) and adenoid size (r=0.24, p <0.01) in all patients. Tonsil grade was positively related to AHI in all four age groups. Adenoid size was positively related to AHI in the toddler, preschool, school groups, but not in the adolescent group (r=0.11, p=0.37). Tonsil grade and adenoid size were both positively related to AHI in obese and non-obese children. In the regression model, obesity (OR=2.89; 95% CI 1.47-5.68), tonsillar hypertrophy (OR=3.15; 95% CI 2.04-4.88), and adenoidal hypertrophy (OR=1.89; 95% CI 1.19-3.00) significantly increased OSA risk. Adenotonsillar hypertrophy and obesity are the major determinants of OSA in children. However, the influence of adenoid size decreases in adolescence.

1 January 2016 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
YCYung-Sen Chang
Yung-Sen Chang
MLMing-Hung Lin
Ming-Hung Lin
JLJyh-Hong Lee
Jyh-Hong Lee
PLPei-Lin Lee
Pei-Lin Lee
YDYang-Shia Dai
Yang-Shia Dai
BCBor-Luen Chiang
Bor-Luen Chiang
Atopic dermatitis (AD) is a common chronic, relapsing, pruritic inflammatory skin disease affecting 15% to 30% of all children and 2% to 10% of all adults.1 Disturbed sleep is reported in 47% to 60% of children with AD and is a major factor leading to an impaired quality of life.2-4 At present, limited studies are available to guide effective clinical management of sleep disturbances in AD. Some investigators5,6 have studied whether treatment targeted at skin inflammation in patients with AD also improves their sleep, but the results have been inconsistent, and most of these studies used a subjective visual analog scale rather than objective measures to evaluate sleep.

1 August 2014 in Pediatrics
Verified
Journal Article
Closed access
PDF file
YCYung-Sen Chang
Yung-Sen Chang
YCYen-Ting Chou
Yen-Ting Chou
JLJyh-Hong Lee
Jyh-Hong Lee
PLPei-Lin Lee
Pei-Lin Lee
YDYang-Shia Dai
Yang-Shia Dai
BCBor-Luen Chiang
Bor-Luen Chiang
BACKGROUND AND OBJECTIVES: Sleep disturbance is common in patients with atopic dermatitis (AD). However, studies have largely been questionnaire-based, and the pathophysiology remains unclear. The aims of this study were to determine objective characteristics of sleep disturbance in children with AD and explore contributing factors and clinical predictors. METHODS: Sleep parameters were measured by actigraphy and polysomnography in 72 patients with AD and 32 controls ages 1 to 18 years. Urinary 6-sulfatoxymelatonin levels, serum cytokines, and total and allergen-specific immunoglobulin E (IgE) levels were also measured. RESULTS: The patients with AD had significantly reduced sleep efficiency, longer sleep onset latency, more sleep fragmentation, and less nonrapid eye movement sleep. Results from actigraphy correlated well with those from polysomnography. The AD disease severity was associated with sleep disturbance (r = 0.55−0.7), and a Scoring Atopic Dermatitis index of ≥48.7 predicted poor sleep efficiency with a sensitivity of 83.3% and a specificity of 75% (area under the curve = 0.81, P = .001). Lower nocturnal melatonin secretion was significantly associated with sleep disturbance in the patients with AD. Other correlates of sleep disturbance included pruritus, scratching movements, higher total serum IgE levels, and allergic sensitization to dust mite and staphylococcal enterotoxins. CONCLUSIONS: Poor sleep efficiency is common in children with AD and can be predicted by the Scoring Atopic Dermatitis index. Melatonin and IgE might play a role in the sleep disturbance. Further studies are required to explore the mechanisms and clinical implications, and actigraphy could serve as a useful evaluating tool.

24 January 2012 in International Journal of Obesity
Verified
Journal Article
Closed access
KKK-T Kang
K-T Kang
PLPei-Lin Lee
Pei-Lin Lee
WEN-CHIN WENGWEN-CHIN WENG
WEN-CHIN WENG
WHW-C Hsu
W-C Hsu


1 July 2003 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
PLPei-Lin Lee
Pei-Lin Lee
JJJIH-SHUIN JERNG
JIH-SHUIN JERNG
YCY.L. Chang
Y.L. Chang
CCC.F. Chen
C.F. Chen
PHPo-Ren Hsueh
Po-Ren Hsueh
KLK.T. Luh
K.T. Luh
Mortality remains high among patients with pulmonary tuberculosis requiring mechanical ventilation (TBMV). This study was carried out to establish the mortality rates of TBMV and to identify factors that contribute to in-hospital mortality.From January 1996–April 2001, there were 825 patients with active pulmonary tuberculosis at the National Taiwan University Hospital, Taipei, Taiwan. Of these, 41 suffered acute respiratory failure and required mechanical ventilation in the intensive care unit (ICU). Of these 41 patients, 38 were followed up for 180 days. In-hospital deaths were documented in the medical records and all possible parameters contributing to mortality were collected.Of the 41 patients, 27 died in the hospital and 14 were discharged alive (in-hospital mortality rate 65.9%), with (mean±sd) 40.7±35.4 admission days before death. Of the 27 that died, 25 died during ICU admission and two died after being transferred to the ward. The mortality rate for the 180-day monitoring period was 79%. Factors contributing to in-hospital mortality included consolidations on chest radiographs and multiple organ failure.The mortality rate in the patients with pulmonary tuberculosis requiring mechanical ventilation is very high, with two factors affecting in-hospital mortality. These factors were multiple organ failure and consolidation on chest radiographs.